5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.49▼ | 3.52▼ | 3.51▼ | 3.42▲ | 2.96▲ |
MA10 | 3.51▼ | 3.53▼ | 3.54▼ | 3.16▲ | 2.80▲ |
MA20 | 3.52▼ | 3.55▼ | 3.60▼ | 2.97▲ | 3.25▲ |
MA50 | 3.53▼ | 3.50▼ | 3.27▲ | 2.77▲ | 3.40▲ |
MA100 | 3.55▼ | 3.24▲ | 3.03▲ | 3.33▲ | 4.00▼ |
MA200 | 3.60▼ | 3.01▲ | 2.96▲ | 3.42▲ | 3.76▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.014▼ | -0.035▼ | 0.087▲ | 0.025▲ |
RSI | 25.892▼ | 43.997▼ | 51.702▲ | 64.706▲ | 53.627▲ |
STOCH | 4.556▼ | 15.352▼ | 12.972▼ | 83.933▲ | 56.567 |
WILL %R | -92.857▼ | -97.778▼ | -97.778▼ | -26.549 | -19.032▲ |
CCI | -125.926▼ | -183.122▼ | -164.758▼ | 133.230▲ | 108.222▲ |
▲ GAP | $TTI Open Gap Up %2 | Set Alert |
Thursday, June 12, 2025 12:07 PM
Tvardi advances fibrosis drug TTI-101 in IPF and liver cancer as Piper initiates with $78 target; merger boosts cash runway into late 2026.
|
Thursday, June 12, 2025 06:00 AM
TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that its senior management will be participating in two investor conferences in late June.
|
Thursday, June 12, 2025 02:39 AM
BTIG also maintained a Buy rating on Tvardi, with a $55 target, emphasizing TTI-101’s potential to reverse disease progression in IPF. Lucid (NASDAQ:LCID) Capital Markets set a $42 target on Tvardi, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 3.68 | 3.74 | 3.47 | 3.48 | 1,515,100 |
12/06/25 | 3.71 | 3.75 | 3.51 | 3.59 | 2,283,100 |
11/06/25 | 3.26 | 3.78 | 3.25 | 3.77 | 8,763,500 |
10/06/25 | 3.07 | 3.265 | 3.07 | 3.18 | 944,208 |
09/06/25 | 3.00 | 3.14 | 2.995 | 3.06 | 881,205 |
06/06/25 | 2.94 | 3.00 | 2.93 | 2.97 | 779,500 |
05/06/25 | 2.90 | 2.93 | 2.8443 | 2.89 | 1,175,831 |
04/06/25 | 3.00 | 3.05 | 2.86 | 2.86 | 950,509 |
03/06/25 | 2.80 | 3.01 | 2.70 | 2.98 | 1,016,495 |
02/06/25 | 2.76 | 2.87 | 2.725 | 2.80 | 1,207,236 |
|
|
||||
|
|
||||
|
|